Nisoldipinum [Inn-Latin] en es it fr

Nisoldipinum [Inn-Latin] Brand names, Nisoldipinum [Inn-Latin] Analogs

Nisoldipinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Nisoldipinum [Inn-Latin] Chemical_Formula

C20H24N2O6

Nisoldipinum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic/nisoldipine.htm

Nisoldipinum [Inn-Latin] fda sheet

Nisoldipinum [Inn-Latin] msds (material safety sheet)

Nisoldipinum [Inn-Latin] Synthesis Reference

No information avaliable

Nisoldipinum [Inn-Latin] Molecular Weight

388.414 g/mol

Nisoldipinum [Inn-Latin] Melting Point

No information avaliable

Nisoldipinum [Inn-Latin] H2O Solubility

No information avaliable

Nisoldipinum [Inn-Latin] State

Solid

Nisoldipinum [Inn-Latin] LogP

3.475

Nisoldipinum [Inn-Latin] Dosage Forms

No information avaliable

Nisoldipinum [Inn-Latin] Indication

Hypertension

Nisoldipinum [Inn-Latin] Pharmacology

Nisoldipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina. Nisoldipine is similar to other peripheral vasodilators. Nisoldipine inhibits the influx of extra cellular calcium across the myocardial and vascular smooth muscle cell membranes possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

Nisoldipinum [Inn-Latin] Absorption

No information avaliable

Nisoldipinum [Inn-Latin] side effects and Toxicity

No information avaliable

Nisoldipinum [Inn-Latin] Patient Information

Nisoldipinum [Inn-Latin] Organisms Affected

Humans and other mammals